Skip to main content
. 2022 Aug 15:10.1002/acr.24894. Online ahead of print. doi: 10.1002/acr.24894

Figure 3.

Figure 3

Predicted antibody titers following second dose by number of symptoms in patients with chronic inflammatory disease (CID) and healthy control subjects. The regression model depicts change in anti–SARS–CoV‐2 spike IgG ± antibody titer with each increase of 1 endorsed symptom following second dose of vaccine in CID patients and healthy controls.